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Abstract 
Background: Herb-partitioned moxibustion (HPM) at Tianshu (ST25) and Qihai (RN6) has been used to treat Crohn’s 
disease (CD). Injury to intestinal epithelial tight junctions (TJs) is the leading cause of CD onset with under expres-
sion of TJ-related proteins such as occludin, claudin-1, and zonula occludens protein-1 (ZO-1). This study aimed to 
investigate whether HPM can change the permeability of the intestinal epithelial barrier by affecting the expression of 
colonic epithelial TJ-related proteins in vitro.
Methods: Forty-eight male Sprague–Dawley rats were randomly divided into four groups of twelve rats: normal 
control (NC) group; model control (MC) group; herb-partitioned moxibustion (HPM) group; and mesalazine control 
(MESA) group. The rats in the latter three groups were given trinitrobenzene sulfonic acid (TNBS) enemas to establish 
CD models. The HPM group was treated with HPM at Tianshu (ST25) and Qihai (RN6) once daily for 14 consecutive 
days, while the MESA group was given mesalazine solution (at the proportion of 0.018:1) by lavage twice daily for 
the same period. After the treatment period, the colon tissues from all groups were partly processed for macroscopic 
damage assessment and histological observation, and partly purified and cultured in vitro to examine the permeabil-
ity of the intestinal epithelial cell barrier by trans-epithelial electrical resistance (TEER). Western blot and fluorescence 
quantitative polymerase chain reaction (FQ-PCR) analyses were performed to observe the expression of occludin, 
claudin-1, and ZO-1 proteins and mRNAs, respectively.
Results: In the HPM and MESA groups, the typical CD macroscopic damage, i.e., inflammatory cell infiltration in 
colonic mucosa and submucosa, submucosal lymphoid follicular hyperplasia, hyperemia and edema, and morpho-
logical changes were improved to different degrees in the colonic tissues (HPM, MESA vs. MC for macroscopic score of 
colonic damage: all P < 0.001). The decreasing tendencies were minor for colonic TEER values (HPM, MESA vs. MC: all 
P < 0.001), and expression of intestinal epithelial TJ-related proteins (HPM, MESA vs. MC: all P < 0.05) and mRNAs (HPM, 
MESA vs. MC: all P < 0.05), especially in the HPM group (HPM vs. MESA for TEER values: P < 0.001).
Conclusions: HPM at Tianshu (ST25) and Qihai (RN6) upregulated the expression of occludin, claudin-1, and ZO-1 in 
TNBS-induced CD model rats.
© 2016 Ji et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Crohn’s disease (CD) is a chronic inflammatory bowel 
disease (IBD) characterized by intestinal inflammatory 
changes induced by abnormal immune responses of the 
host against the intestinal tolerated commensal micro-
flora [1, 2]. Injury to the intestinal epithelial barrier 
(e.g., excessive apoptosis of intestinal epithelial cells) 
and genetic defects in the intestinal epithelial tight junc-
tions (TJs) (e.g., under expression of TJ-related pro-
teins) were reported to be involved in the occurrence 
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and development of CD [3]. Intestinal mucosal tumor 
necrosis factor-alpha (TNF-α) and tumor necrosis factor 
receptor1 (TNFR1) were overactive in patients with mild 
to moderate CD [4, 5]. Malformation and dysfunction of 
intestinal epithelial TJs were found in patients with IBDs 
[6, 7], and related to under expression or abnormal distri-
bution of intestinal epithelial TJ-related proteins [8].
Intestinal epithelial TJs are related to the permeability 
of the intestinal epithelial barrier [9, 10]. Changes in the 
permeability of the intestinal epithelial barrier are the 
leading pathologic alterations in CD [11, 12]. Occludin, 
claudin-1, and zonula occludens protein-1 (ZO-1) are 
major proteins for maintaining TJ permeability [8]. Dur-
ing active and non-active periods of CD, the expression 
of occludin, claudin-1, ZO-1 proteins and mRNAs were 
significantly reduced in the colonic mucosa, followed by 
increasing permeability of the intestinal epithelium and 
injury to the intestinal epithelial barrier [13, 14].
The goals in CD treatment are remission of inflamma-
tion, recovery of mucosa, prevention of relapse, avoidance 
of surgical intervention and minimization of the possibility 
of cancer development [15]. 5-Aminosalicylates (5-ASA) 
and thiopurines are clinically used in treatments for IBD 
[16]. 5-ASA preparations (e.g., mesalazine) are the first-line 
medicines for IBD treatment in mild to moderate ulcerative 
colitis (UC) [17]. However, they were found to be no more 
effective than placebo for active CD [18]. Therefore, the 
European Crohn’s and Colitis Organization has recognized 
the efficiency of mesalazine as “limited” [19]. Application 
of thiopurines in mild to moderate CD patients is limited 
because of their severe side effects including abnormities 
in liver and renal functions, digestive intolerance and with-
drawal reactions [20]. In consideration of this, alternatives 
that offer safe and highly effective treatment are urgently 
needed for patients with mild to moderate CD.
Previous clinical and experimental studies showed that 
herb-partitioned moxibustion (HPM) was effective in reliev-
ing abdominal pain, diarrhea and other gastrointestinal 
symptoms, as well as improving the Crohn’s disease activity 
index in patients [4, 5]. HPM was able to significantly reduce 
the abnormal increases in TNF-α and TNFR1 in the intes-
tinal mucosa [5]. HPM not only decreased the apoptosis of 
colonic epithelial cells, but also enhanced the expression of 
colonic epithelial TJ-related proteins in vitro [21, 22].
This study aims to investigate whether HPM would 
change the permeability of the intestinal epithelial bar-




Forty-eight male Sprague-Dawley rats (150 ± 10 g), aged 
6–8  weeks, were supplied by the Experimental Animal 
Center, Shanghai University of Traditional Chinese Med-
icine (China). The experiments were approved by Ethics 
Committee of Shanghai University of Traditional Chi-
nese Medicine (No. 2013025; Additional files 1 and 2). 
Each animal was free of any known pathogens and only 
used once. All rats were housed in a light-controlled 
room (12-h/12-h light/dark cycle with lights on at 07:00 
am), with constant temperature (22 ± 1 °C) and humidity 
(42 ± 5 %). Prior to modeling, the rats were housed with 
six companions in each cage, and had free access to food 
and water. The animal studies were performed following 
the ARRIVE guideline (Additional file 3).
The 48 male rats were allocated into four groups by a 
randomized block design. After weighing on a scale, the 
rats were ranked according to their body weight, and the 
numbers 1 through 48 were written on the tails of the 
rats in ascending order. According to this order, sets off 
our rats with similar approximate weights comprised one 
block, and were simultaneously given 48 random num-
bers taken from the random number table (from line 6 
row 8, left to right). The four rats in each block were rear-
ranged by their random numbers into ascending order, 
and then allocated into four groups of twelve rats: normal 
control (NC) group; model control (MC) group; herb-
partitioned moxibustion (HPM) group; and mesalazine 
control (MESA) group.
The CD models were prepared according to Mor-
ris’ method [23]. Briefly, all rats were given only water 
for 24  h before modeling. After being weighed on the 
scale, the rats in all four groups were anesthetized with 
sodium pentobarbital (30  mg/kg 2  %; Sigma Chemical 
Co., USA) by intraperitoneal injection. The rats in the 
MC, HPM, and MESA groups were given trinitrobenzene 
sulfonic acid (TNBS; Sigma Chemical Co., USA) ene-
mas(0.5 mL/100 g; formula: TNBS/50 % ethanol = 2:1), 
while those in the NC group were given enemas with the 
same dose of normal saline. The rats were fixed in the 
handstand position for 1 min while the rubber tubes con-
taining the enema solution were retained in the gut cavity 
at 6–8  cm in depth to ensure an adequate drug action, 
and the tubes were then withdrawn. This procedure was 
repeated on days 7, 14, 21, and 28. When the CD mod-
eling procedure was completed, two rats from each group 
were arbitrarily selected (by picking a number out of a 
box) to examine whether the modeling was sufficient by 
observing hematoxylin and eosinstained colonic tissues 
under a light microscope (Leica Microsystems GmbH, 
Germany).
Herbal cake and moxi cone preparation
The herbal powder formula was as follows: Fuzi (radix 
Aconiti carmichaeli) (10 g; Sichuan, China), Rougui (Cin-
namomum cassia Presl) (2  g; Guanxi, China), Danshen 
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(radix Salviae miltiorrhizae) (3  g; Anhui, China), Hong-
hua (Carthamus tinctorius L.) (3  g; Henan, China), and 
Muxiang (Saussurea costus) (2 g; Yunnan, China). Decoc-
tion pieces of these traditional Chinese medicines were 
mixed, ground into a fine powder, passed through a 150-
mesh sieve three times, and stored in dry and dark condi-
tions at room temperature (25 °C). For use, 2.5 g of herbal 
powder was fully mixed with 3 g of Shaoxing wine into a 
thick paste, and then shaped into herbal cakes (1 cm in 
diameter, 0.6 cm in height) in a herbal cake mold for the 
experimental rats.
Moxi cones (10  mg in weight, 0.6  cm in diameter, 
0.6 cm in height) were made by hand using refined mug-
wort floss (Huatuo, Suzhou, China).
Treatments
After excluding the rats arbitrarily selected from each 
group to examine whether the CD modeling was suffi-
cient, the remaining 10 rats in each group were processed 
as described below.
All rats received the same fixation before treatment. 
The devices were adjusted until the rats felt comfortable 
and stopped struggling. When HPM was applied to the 
HPM group, the rats in the other three groups received 
the same fixation for the same duration.
The NC and MC groups received no treatment. For the 
HPM group, the fur of the lower abdomen was carefully 
shaved to expose the chosen acupoints, Tianshu (ST25) 
and Qihai (RN6). The moxa cones were ignited with an 
incense stick after placement on the herbal cake at Tian-
shu (ST25) and Qihai (RN6). Three moxa cones were 
used for each rat in a single treatment for 10  min. The 
rats received the same treatment once daily for 14 days. 
For the MESA group, mesalazine solution (Dr. FalkP-
harma, Germany) at the proportion of 0.018:1 was fed by 
lavage [24]. The rats received the same treatment twice 
daily for 14 days.
Assessment of macroscopic colonic damage
After the treatment period, all rats in the different groups 
were ethically euthanized with sodium pentobarbital 
(30 mg/kg 2 %; Sigma Chemical Co., USA) by intraperito-
neal injection. Colonic tissues (2–3 cm in length; 6–8 cm 
away from the anus) were taken and rinsed 5–10 times 
with sterile phosphate-buffered saline (PBS) containing 
antibiotics. Assessment of macroscopic colonic damage 
was conducted according to previously published criteria 
[25], as shown in Table  1. The severity of inflammation 
was assessed using the same criteria.
Histological observation
Colonic tissues (1  cm) were removed for histological 
observation. The tissues were washed in ice-cold normal 
saline, fixed in 10 % formalin, embedded in paraffin, cut 
into 4  µm thin sections, and adhered onto plain glass 
slides. The sections were then baked in an oven at 58 °C 
for 24  h for dewaxing, stained with hematoxylin and 
eosin, dehydrated in 95, 90, and 70  % ethanol, cleaned 
up in xylene, mounted in Permount or Histoclad, and 
observed at 200×  magnification under an Olympus 
CX31 optical microscope (Olympus, Japan) at 2.80 V and 
2.74 A. Images were obtained with a Canon A640 camera 
(Canon, Japan).
Establishment of an in vitro intestinal epithelial barrier 
model
The remaining tissues were cut into pieces with ophthal-
mic scissors, and digested with 0.4 % type IV collagenase 
for 2 h in an incubator at 37 °C and 5 % CO2. The super-
natants were centrifuged at 5000×g for 10  min. After 
the supernatants were discarded, the cell pellets were 
resuspended and seeded into culture dishes with Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma-Aldrich 
Chemical Co., USA) containing 10 % fetal bovine serum 
(Sigma Chemical Co., USA) in an incubator at 37 °C and 
5 % CO2. The culture medium was changed every other 
day. Colonic epithelial cells were purified, digested with 
trypsin, and resuspended in complete medium before 
counting. Cells (1  ×  103) were taken and placed in 
48-well plates for adherence and observation. Wells with 
high proportions of epithelial cells were expanded in cul-
ture. The above operations were repeated until most of 
the epithelial cells were visible under a light microscope 
(Leica Microsystems GmbH, Germany). The culture was 
continued for 7 days [26] until a complete epithelial bar-
rier was formed from normal colonic epithelial cells. 




Involving several bowel loops 2
Strictures None 0
mild 2
Severe, proximal dilatation 3
Ulcers None 0
Linear ulceration <1 cm 1
Two linear ulcers <1 cm 2
More sites of ulceration or one large ulcer >1 cm 3
Wall thickness Less than 1 mm 0
1–3 mm 1
More than 1 mm 2
Maximum score 10
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TEER, western blot, and fluorescence quantitative PCR 
(FQ-PCR) analyses of colonic epithelial cells were per-
formed in each group.
Measurement of colonic TEER
Cultured cells in the different groups were washed once 
with PBS and digested with 0.25 % trypsin [27, 28]. After 
adding culture medium and terminating the digestion 
process, the cells were counted and adjusted to a density 
of 2.5 × 105 cells/mL. Transwell chambers for measuring 
transmembrane resistance were placed in 24-wellplates. 
Complete medium (600  µL) was added to the lower 
chamber, while a cell suspension (200 µL) was added to 
the upper chamber and cultured for 24 h at 37 °C and 5 % 
CO2. The medium in the upper and lower chambers of 
the transwell chambers was replaced with 200 and 600 µL 
of medium, respectively. A small chamber with medium 
only was set as a negative control. The plates were meas-
ured in a Millicell ERS-2 Epithelial Volt-Ohm Meter 
(Millipore, USA) after vertical plug-in of an electrode 
into three slots on the chamber wall. The average of these 
three values was taken for statistical analysis. The room 
temperature was strictly controlled at 25  °C, because 
TEER values were reported to be highly sensitive to the 
environmental temperature [29].
Detection of occludin, claudin‑1, and ZO‑1 expression 
in the rat colonic epithelial cells cultured in vitro
Cells (2 × 106) were taken from each group, added to a 
celllysis buffer (100 µL) until full cleavage was achieved, 
and boiled (100  °C) for 5  min. The insoluble material 
was removed by centrifugation (5000×g for 5 min). The 
proteins in each sample (50 µL) were separated by poly-
acrylamide gel electrophoresis and transferred to nitro-
cellulose membranes. The membranes were sequentially 
blocked with 5  % nonfat milk in PBS for 2  h and 5  % 
bovine serum albumin in PBS at 4 °C overnight, and then 
incubated with primary antibodies for 90  min at room 
temperature. The primary antibodies used were rab-
bit polyclonal immunoglobulin (IgG) antibodies against 
occludin (Ab31721; Abcam, UK; 1:250 dilution), clau-
din-1 (Ab15098; Abcam, UK; 1:25 dilution), and ZO-1 
(Sc-10804; Santa Cruz Biotechnology, USA; 1:100 dilu-
tion). Peroxidase-conjugated goat anti-rabbit IgG (A0208; 
Beyotime, China; 1:1000 dilution) and chemilumines-
cence fluids A and B (1:1) were incubated with the mem-
branes for 1 h and 1 min, respectively. The reactive bands 
were detected by chemiluminescent reagents (170-5061; 
Bio-Rad, USA). A Tanon-5200imager (Tanon, China) was 
employed for image acquisition, and Image-pro plus 6.0 
software (MediaCybernetics, USA) was used to analyze 
the gray values of the bands. All the grey values of the 
bands were normalized by the value for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH).
FQ‑PCR detection of occludin, claudin‑1, and ZO‑1 mRNA 
expression in the rat colonic epithelial cells cultured 
in vitro
Total cellular RNA was separated from the rat colonic 
epithelial cell samples using Trizol reagent (1596-026; 
Invitrogen, USA). Three micrograms of the total RNA 
wasused as a template for reverse transcription of 
cDNAs. The cDNAs were synthesized by reverse tran-
scription using a RevertAid cDNA Synthesis Kit (#K1622; 
Fermentas, USA) in accordance with the manufacturer’s 
instructions, and then amplified, the primer sequences 
used for PCR amplification reaction were shown in 
Table  2. The following cycling conditions were used: 
reverse transcription at 37 °C for 1 h, inactivation of the 
MMLV RT enzyme at 95  °C for 5 min, and 40 cycles of 
50 °C for 2 min, 95 °C for 5 min, 95 °C for 15 s, and 60 °C 
for 45  s. Real-time PCR was performed with a Quanti-
Tect SYBR Green PCR Kit (#K0223; Thermo Fisher Sci-
entific, USA) using an ABI 7500 real-time PCR system 
and SDS software (Applied Biosystems, USA). Data for 
the mRNA levels were calculated as the relative amounts 
normalized to that of GAPDH.
Statistical analysis
Statistical data were represented in graphs as 
mean ± standard deviation (SD). Statistical analyses were 
performed using SPSS 16.0 software (SPSS, USA). Dif-
ferences within experimental groups were compared by 
one-way analysis of variance (ANOVA). LSD test was 
performed for multiple group comparison. Values of 
P < 0.05 were considered statistically significant.
Results
Colonic histopathological observations in the different 
groups
In the normal group (Fig.  1a), the colonic mucosa was 
intact, and the morphology of submucosal and muscular 
tissues was normal. In the MC group (Fig. 1b), there were 
large numbers of eosinophils with marked inflamma-
tory cell infiltration in colonic mucosa and submucosa, 
and obvious submucosal lymphoid follicular hyperplasia, 
epithelial damage, submucosal hyperemia and edema, 
fibroblast proliferation, and muscle tissue damage, as 
well as epithelioid reactions, giant cells, and other typi-
cal pathological intestinal changes of CD. In the MESA 
group (Fig. 1c), there were eosinophils and inflammatory 
cell infiltration in colonic mucosa and submucosa, sub-
mucosal hyperemia and edema, fibroblast proliferation, 
small amounts of epithelioid reactions and giant cells, 
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and slightly disordered layers of tissue morphology. In 
the HPM group (Fig. 1d), there were only small amounts 
of inflammatory cell infiltration in colonic mucosa and 
submucosa, mild hyperemia, small amounts of fibroblast 
proliferation, and normal morphology of mucosal, sub-
mucosal, and muscular tissues.
Scores for macroscopic colonic damage in the different 
groups
Compared with the NC group, the MC, MESA, and 
HPM groups showed significant increases in the macro-
scopic scores for colonic damage (P = 0.000, P = 0.000, 
P =  0.024; Fig. 2). However, the macroscopic scores for 
colonic damage in the MESA and HPM groups were sig-
nificantly lower than that in the MC group (P =  0.000, 
P =  0.000), although there was no significant difference 
between these two groups (P =  0.075). Both HPM and 
MESA therapy could significantly improve the macro-
scopic colonic mucosal damage in CD.
Comparison of TEER values in the different groups
As shown in Fig. 3, there was a significant decrease in the 
colonic TEER values in the MC group compared with the 
NC group (P =  0.000). There were significant increases 
in the colonic TEER values in both the HPM and MESA 
groups compared with the MC group (P  =  0.000, 
Table 2 The sequence of the forward primer and reverse primer used for FQ-PCR assays
Name Primer sense Primer sequence (5′ → 3′) Amplification product (bp)
GAPDH Forward 5′-CCGAGGGCCCACTAAAGG-3′ 116
Reverse 5′-GCTGTTGAAGTCACAGGAGACAA-3′
Occludin Forward 5′-GGGACAGAGCCTATGGAA-3′ 191
Reverse 5′-GGAAGCGATGAAGCAAAA-3′
Claudin-1 Forward 5′-CTGGCTTCGCTGGGATGGA -3′ 100
Reverse 5′-TGGCCTGAGCAGTCACGATGTT-3′
ZO-1 Forward 5′-GATGAGCGGGCTACCTTA-3′ 126
Reverse 5′-ATGGGAGCGAACTGAATG-3′
Fig. 1 Histopathological observation of the colon tissue. Hematoxylin and eosin staining method, ×200. a NC group; b MC group; c MESA group; d 
HPM group
Fig. 2 Macroscopic score of colonic damage. NC normal control 
group, MC model control group, MESA mesalazine group, and 
HPM herb-partitioned moxibustion group. ★P < 0.001 versus NC, ★★P < 0.05 versus NC; △P < 0.001 versus MC. The data of macro-
scopical score do not have normal distribution, the box-plot is used 
to express, as shown below. The NC group has the same value, so 
the box-plot only have one straight line. The maximum value is equal 
to the upper quantile and the minimum value is equal to the lower 
quantile in MC group. The maximum value is equal to the upper 
quantile in MESA group. The maximum value is equal to the upper 
quantile and the minimum value is equal to the lower quantile in 
HPM group
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P =  0.000), while the HPM group had significantly bet-
ter TEER values than the MESA group (P  =  0.000).
There were also significant differences in the HPM and 
MESA groups compared with the NC group (P = 0.000, 
P = 0.000).
Expression of occludin, claudin‑1, and ZO‑1 proteins in the 
different groups
For occludin protein expression (Fig. 4a), there was a sig-
nificant decrease in the MC group compared with the NC 
group (P = 0.000), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.025, 
P  =  0.019), and no significant difference between the 
HPM group and the MESA group (P =  0.859), but sig-
nificant differences in the HPM and MESA groups com-
pared with the NC group (P  =  0.001, P  =  0.000). For 
claudin-1 protein expression (Fig. 4b), there was a signifi-
cant decrease in the MC group compared with the NC 
group (P = 0.000), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.001, 
P  =  0.002), no significant difference between the HPM 
group and the MESA group (P = 0.535), and no signifi-
cant differences in the HPM and MESA groups com-
pared with the NC group (P  =  0.196, P  =  0.073). For 
ZO-1 protein expression (Fig.  4c), there was a signifi-
cant decrease in the MC group compared with the NC 
group (P = 0.008), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.038, 
P  =  0.046), no significant difference between the HPM 
group and the MESA group (P = 0.899), and no signifi-
cant differences in the HPM and MESA groups compared 
with the NC group (P = 0.336, P = 0.282).
Expression of occludin, claudin‑1, and ZO‑1 mRNAs in the 
different groups
For occludin mRNA expression (Fig. 5a), there was a sig-
nificant decrease in the MC group compared with the NC 
group (P = 0.000), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.028, 
P  =  0.043), and no significant difference between the 
HPM group and the MESA group (P =  0.846), but still 
significant differences in the HPM and MESA groups 
compared with the NC group (P = 0.000, P = 0.000). For 
claudin-1 mRNA expression (Fig. 5b), there was a signifi-
cant decrease in the MC group compared with the NC 
group (P = 0.000), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.035, 
P  =  0.039), and no significant difference between the 
HPM group and the MESA group (P =  0.968), but still 
significant differences in the HPM and MESA groups 
compared with the NC group (P  =  0.048, P  =  0.044). 
For ZO-1 mRNA expression (Fig. 5c), there was a signifi-
cant decrease in the MC group compared with the NC 
group (P = 0.000), significant increases in the HPM and 
MESA groups compared with the MC group (P = 0.017, 
P  =  0.044), and no significant difference between the 
HPM group and the MESA group (P =  0.684), but still 
significant differences in the HPM and MESA groups 
compared with the NC group (P = 0.001, P = 0.000).
Discussion
This study has demonstrated the effects of HPM on 
repairing the colonic epithelial barrier and upregulating 
the expression of occludin, claudin-1, and ZO-1 in vitro. 
In the study, we first observed both macroscopic and 
histological damage to the colonic tissues from the dif-
ferent groups. Immediately after the colonic tissues were 
removed and washed, we assessed the scores for adhe-
sions, strictures, ulcers, and wall thickness of the colonic 
tissues. In the NC group, the colonic tissues showed mild 
hyperemia and edema, but no mucosal erosion or ulcers, 
which might have arisen through stimulation during the 
surgery process. Almost no signs of tissue adhesions and 
strictures were observed, and the wall thickness was nor-
mal. In the MC group, severe hyperemia and edema were 
generally observed in most rats, while deep and multiple 
ulcers were common. In several rats, we also observed 
slight adhesions of the adjacent colonic tissues, accom-
panied by loss of elasticity and smoothness of colonic 
tissues, and slight increases in wall thickness. This was 
because that our CD modeling procedure could only imi-
tate the incipient acute colonic inflammation, which is 
characterized by mucosal hyperemia, edema, and ulcers. 
However, the symptoms of tissue adhesions, strictures, 
Fig. 3 Transepithelial electrical resistance values of each group. NC 
normal control group, MC model control group, MESA mesalazine 
group and HPM herb-partitioned moxibustion group. ∗P < 0.01 versus 
NC; #P < 0.01 versus MC; ▲P < 0.01 versus MESA. The standard devia-
tion in MC group (163.53 ± 0.77), MESA group (180.13 ± 1.09) and 
HPM group (188.60 ± 1.07) is small and not shown in the graph
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and intestinal wall stiffness were mainly the results of 
chronic recurrent inflammation. Compared with the MC 
group, the MESA and HPM groups showed remarkable 
signs of inflammation remission, as the mucosal hypere-
mia, edema, and ulcers were moderate and localized, and 
adhesions and strictures were barely observed.
By light microscopy, we observed pathological changes 
of the colonic tissues in the CD, HPM, and MESA 
groups. In tissues taken from the MC group, eosinophils 
and inflammatory cell infiltration in colonic mucosa and 
submucosa, and obvious submucosal hyperemia and 
edema, as well as obvious lymphoid follicles, fibroblast 
proliferation, and other typical CD pathological changes 
were observed under a light microscope. After treatment 
with mesalazine, these pathological changes were not 
improved. After treatment with HPM, there was only a 
small amount of inflammatory cell infiltration in colonic 
mucosa and submucosa, mild hyperemia, and scattered 
fibroblast proliferation among normal morphology of the 
mucosal, submucosal, and muscular tissues.
We then examined the TEER of the in  vitro cultured 
colonic epithelial cells from the different groups. TEER 
determination is widely used to functionally analyze TJ 
dynamics in cell culture models of physiological barriers 
Fig. 4 Expression of colonic epithelial TJ-related proteins occludin, claudin-1 and ZO-1 in each group. a Expression of occludin in each group. b 
Expression of claudin-1 in each group. c Expression of ZO-1 in each group. NC normal control group, MC model control group, MESA mesalazine 
group, and HPM herb-partitioned moxibustion group. ∗P < 0.01 versus NC; #P < 0.01 versus MC; ##P < 0.05 versus MC
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[30–32], which can be used to evaluate the paracellu-
lar permeability  of epithelial monolayers. A decrease in 
TEER was associated with disruption of TJs and subtle 
changes in the cytoskeletal structure, resulting in a sub-
sequent increase in the paracellular permeability of the 
epithelial monolayer [33]. In the present study, we found 
significant decreases in the TEER values in the MC group, 
but increases to different degrees in the HPM and MESA 
groups, with the HPM group showing larger rising trends. 
These findings suggested that during the pathological 
process of CD, the structure of TJs was impaired, leading 
to a subsequent decrease in the paracellular permeabil-
ity of the epithelial monolayer. However, both HPM and 
mesalazine treatment can recover or reduce the abnor-
mally increased colonic epithelial permeability in CD, 
and HPM possesses the advantages of repairing TJs and 
increasing the permeability of the epithelial monolayer.
The intestinal epithelium creates a chemical and 
mechanical barrier that separates the host from microbes 
[34]. The chemical barrier consists of mucus, peptides, and 
antimicrobial proteins secreted by goblet cells and Paneth 
cells, while the mechanical barrier is composed of differ-
ent kinds of enterocytes and TJs to join the cells together. 
These barriers are responsible for permeability, i.e., selec-
tive absorption of water and nutrients in the gut lumen 
through either transepithelial or paracellular transport. TJs 
are multimolecular complexes that seal the intercellular 
space between adjacent epithelial cells [35] and act as a dif-
fusion barrier to control the transportation of ions, macro-
molecules, and immune cells in the paracellular pathway 
[36], and are therefore the major determinants of epithelial 
permeability [37]. TJs maintain symbiosis within intestinal 
microflora and prevent infection or inflammation induced 
by bacterial translocation [38].
The TJ-related proteins of the intestinal epithelial 
barrier are mainly located at the top side of the enteric 
cavity among intestinal epithelial cells, then zonally sur-
round the side wall and seal up the intestinal epithelial 
gap. TJs are composed of three transmembrane protein 
families [39]: claudins, junctional adhesion molecule 
(JAM) proteins, and TJ-associated Marvel domain pro-
teins (TAMPs) including occludin, tricellulin, and Mar-
vel D3. Claudins control the charge and size-selectivity 
of TJs, while JAMs and TAMPs stabilize TJs and main-
tain epithelial permeability. ZO-1 connects the multi-
protein structure of TJs to peri-junctional actomyosin. 
These three protein families have overlapping and unique 
functions in the regulation of TJs [40]. In this study, 
occludin, claudin-1, and ZO-1 were formed into com-
plex proteins by binding between the C-terminals of the 
TJ transmembrane proteins claudin-1 and occludin and 
Fig. 5 mRNA levels of colonic epithelial TJ-related protein occludin, 
claudin-1 and ZO-1 in each group. a mRNA levels of occludin in each 
group. b mRNA levels of claudin-1 in each group. c mRNA levels of 
ZO-1 in each group. NC normal control group, MC model control 
group, MESA mesalazine group, and HPM herb-partitioned moxibus-
tion group. ∗P < 0.01 versus NC; ∗∗P < 0.05 versus NC; ##P < 0.05 versus 
MC
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the N-terminals of the cytoplasmic-attached protein 
ZO-1 [41], thus allowing their external parts to interact 
with the transmembrane junction proteins of adjacent 
cells. At the same time, the C-terminals of ZO-1 were 
connected with actin of the cytoplasmic cytoskeleton, 
making it possible for claudin-1 to act on these actin 
molecules, and thus participate in maintaining the sta-
bility and selective permeability of TJs [42]. Occludin is 
considered to be fundamental to the structure of TJs [43]. 
Knockout of the occludin gene [28] in epithelial cells can 
cause similar pathological intestinal changes to IBD in 
animals. Reduced expression of intestinal occludin pro-
tein and mRNA was observed in patients with ulcerative 
colitis and CD [3], suggesting the possible involvement of 
occludin in the pathogenesis of IBD. In the present study, 
in  vitro experiments demonstrated radical decreases in 
colonic epithelial occludin protein and mRNA expression 
in the NC group, compared with remarkable recovery of 
the occludin protein and mRNA expression in the MESA 
and HPM groups. The same tendency was observed for 
the other two TJ-related proteins, claudin-1 and ZO-1.
Conclusions
HPM at Tianshu (ST25) and Qihai (RN6) upregulated the 
expression of occludin, claudin-1, and ZO-1 in TNBS-
induced CD model rats.
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